Instructing Immune System to Regenerate Musculoskeletal Tissues via Structurally Programmable Bio-Inks

Project description

3D materials for treating musculoskeletal defects in immunocompromised patients

The immune system not only plays a crucial role in fighting pathogens, but it is also vital for the physiological healing of damaged tissues. Patients with chronic diseases such as diabetes present with a compromised immune system and reduced wound healing capacity. The scope of the EU-funded ImmunoBioInks project is to develop 3D-printed materials to treat musculoskeletal defects in patients with an immune system imbalance. The idea is to combine peptides, hyaluronic acid and nanomaterials into printable scaffolds of defined architecture and with carefully designed mechanical properties that can reprogram the patient’s own immune cells. The interaction of immune cells with this innovative 3D scaffold is expected to trigger the necessary healing response.

Fields of science

• engineering and technology › mechanical engineering › manufacturing engineering › additive manufacturing
• medical and health sciences › medical biotechnology › cells technologies › stem cells
• medical and health sciences › basic medicine › immunology

Programme(s)

• H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility

Topic(s)

• MSCA-IF-2019 - Individual Fellowships

Call for proposal

H2020-MSCA-IF-2019
See other projects for this call

Funding Scheme

MSCA-IF-EF-ST - Standard EF

Coordinator

AO-FORSCHUNGSINSTITUT DAVOS

Address

Clavadelerstrasse 8
7270 Davos Platz
Switzerland

Activity type

Research Organisations

EU contribution

€ 191 149,44